Dyssegmental dysplasia, Silverman-Handmaker type
dis-seg-men-tal dis-PLAY-zhuh, SIL-ver-man HAND-maker type
Also known as: DDSH, Silverman-Handmaker type dyssegmental dysplasia
At a Glance
What is Dyssegmental dysplasia, Silverman-Handmaker type?
Dyssegmental dysplasia, Silverman-Handmaker type, is a rare genetic disorder affecting bone development. It primarily impacts the skeletal system, leading to severe abnormalities in bone segmentation and growth. The condition is caused by mutations in the perlecan gene, which plays a crucial role in cartilage development. Symptoms typically appear before birth and include shortened limbs, a small chest, and facial abnormalities. Early symptoms are often detected via prenatal ultrasound, while later symptoms may include respiratory difficulties and limited mobility. Early diagnosis is critical for managing complications and providing supportive care. The disorder significantly impacts family life, requiring ongoing medical attention and support. Prognosis is generally poor, with many affected individuals experiencing life-threatening complications early in life. Daily life for those affected involves managing physical limitations and frequent medical interventions. Families may face emotional and financial challenges due to the need for specialized care. Despite the severity, some individuals may survive into childhood with intensive medical support. Research is ongoing to better understand and potentially treat this condition.
Medical Definition
Dyssegmental dysplasia, Silverman-Handmaker type, is characterized by severe skeletal abnormalities due to functional null mutations in the perlecan gene. Pathologically, it involves defective cartilage development leading to abnormal bone segmentation. Histological findings include disrupted growth plate architecture and defective endochondral ossification. It is classified under skeletal dysplasias and is inherited in an autosomal recessive pattern. Epidemiologically, it is extremely rare, with most cases identified in consanguineous families. The disease course is typically severe, with high perinatal mortality and significant morbidity in survivors.
Dyssegmental dysplasia, Silverman-Handmaker type Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Severe micromelia manifests as significantly shortened limbs that are disproportionate to the trunk. This condition is caused by mutations in the perlecan gene, which disrupt normal cartilage development and bone growth. Over time, the limb shortening remains constant but may become more pronounced as the child grows. This symptom severely impacts mobility and daily activities, often requiring assistive devices and physical therapy to improve function.
Vertebral segmentation defects present as irregularly formed vertebrae, leading to spinal deformities. These defects arise from disrupted signaling pathways during embryonic development affecting vertebral formation. As the individual grows, these defects can lead to progressive scoliosis or kyphosis. Daily life is impacted by potential pain and limited range of motion, necessitating regular monitoring and possibly surgical intervention.
Facial dysmorphism includes features such as a flat nasal bridge, midface hypoplasia, and micrognathia. These features result from abnormal craniofacial development linked to perlecan gene mutations. The dysmorphic features are present at birth and remain stable throughout life. They can affect social interactions and self-esteem, with supportive therapies and, in some cases, surgical options available to address functional or cosmetic concerns.
Common
Respiratory difficulties occur due to a small thoracic cavity and potential tracheomalacia. These issues stem from underdeveloped ribs and cartilage abnormalities affecting the airway structure. Over time, respiratory challenges may persist or worsen, particularly during infections. Management includes respiratory support and monitoring to prevent complications and improve quality of life.
Joint contractures present as limited movement in the joints, particularly in the elbows and knees. They result from abnormal connective tissue and muscle development associated with the genetic condition. These contractures can become more pronounced with age, leading to further mobility restrictions. Physical therapy and, in some cases, surgical interventions are employed to maintain joint function and improve mobility.
Short stature is evident as a significantly reduced height compared to age-matched peers. This results from impaired bone growth due to cartilage development issues linked to perlecan deficiency. The condition is evident from birth and persists throughout life, often becoming more noticeable as the child grows. It can impact self-esteem and social interactions, with growth hormone therapy being a potential, though limited, treatment option.
Less Common
Hearing loss may manifest as conductive or sensorineural deficits, affecting the ability to perceive sound. This can be due to structural abnormalities in the ear or nerve pathways, influenced by the underlying genetic disorder. Hearing loss can progress or remain stable, depending on the individual case. Early audiological assessment and the use of hearing aids or other assistive devices can help manage this symptom.
Cleft palate is characterized by an opening in the roof of the mouth, affecting feeding and speech. It occurs due to incomplete fusion of the palatal shelves during embryonic development. This condition is present at birth and requires surgical correction to improve function and aesthetics. Early intervention with surgery and speech therapy can significantly enhance quality of life and developmental outcomes.
What Causes Dyssegmental dysplasia, Silverman-Handmaker type?
Dyssegmental dysplasia, Silverman-Handmaker type, is primarily caused by mutations in the perlecan gene, located on chromosome 1p36.12. The perlecan gene encodes a large heparan sulfate proteoglycan that plays a crucial role in cartilage development and maintaining the structural integrity of basement membranes. Mutations in the perlecan gene often result in functional null alleles, leading to a complete loss of protein function. This disruption impairs the assembly of extracellular matrix components, crucial for cartilage and skeletal development. The absence of functional perlecan affects the signaling pathways that regulate chondrocyte proliferation and differentiation. Consequently, this leads to defective cartilage matrix organization and skeletal dysplasia. The lack of perlecan can also trigger an abnormal immune response, potentially involving neuroinflammation. This inflammatory response may contribute to further tissue degeneration and exacerbate skeletal abnormalities. The degeneration of cartilage and other connective tissues results in the characteristic skeletal malformations observed in affected individuals. Symptoms appear in a specific pattern due to the critical role of perlecan in early skeletal development, affecting structures formed during this period. Variability in disease severity among patients can be attributed to the nature of the mutations and their impact on residual perlecan function. Additionally, genetic background and environmental factors may influence the clinical presentation. The absence of perlecan also affects other tissues, such as the nervous system, contributing to the complex phenotype. Understanding the molecular basis of perlecan deficiency provides insights into the pathogenesis of dyssegmental dysplasia, Silverman-Handmaker type.
How is Dyssegmental dysplasia, Silverman-Handmaker type Diagnosed?
Typical age of diagnosis: Dyssegmental dysplasia, Silverman-Handmaker type, is typically diagnosed prenatally or at birth due to the presence of significant skeletal abnormalities that are detectable via ultrasound or physical examination.
Clinicians look for characteristic skeletal abnormalities such as micromelia, short ribs, and a narrow thorax. A detailed family history is important to identify any genetic predisposition or consanguinity. Physical examination often reveals severe limb shortening and facial dysmorphism. This step helps to differentiate dyssegmental dysplasia from other skeletal dysplasias.
Ultrasound is the primary imaging modality used prenatally to detect skeletal abnormalities. Specific abnormalities include vertebral segmentation defects and limb shortening. These findings help confirm the diagnosis of dyssegmental dysplasia and exclude other conditions like thanatophoric dysplasia. Radiographs postnatally can further delineate the extent of skeletal involvement.
Routine laboratory tests may not be specific but can include metabolic panels to rule out other conditions. Biomarkers such as elevated alkaline phosphatase may be noted. Abnormal results guide further genetic testing and specialized consultations. These tests are supportive rather than diagnostic for dyssegmental dysplasia.
Genetic testing focuses on sequencing the perlecan (HSPG2) gene. Mutations typically found are functional null mutations that lead to the condition. Identification of these mutations confirms the diagnosis and aids in genetic counseling. This information is crucial for family planning and understanding recurrence risks.
Dyssegmental dysplasia, Silverman-Handmaker type Treatment Options
Bisphosphonates are used to manage bone density and reduce fracture risk. They work by inhibiting osteoclast-mediated bone resorption. Specific drugs like pamidronate have been used in similar skeletal dysplasias. Clinical evidence for efficacy in dyssegmental dysplasia is limited due to the rarity of the condition. Side effects can include gastrointestinal discomfort and atypical fractures.
Techniques focus on improving mobility and muscle strength through tailored exercises. The goal is to enhance functional independence and quality of life. Sessions are recommended several times a week, with duration depending on individual progress. Measurable outcomes include improved range of motion and muscle strength. Long-term benefits include better physical function and reduced disability.
Surgery may be indicated for severe spinal deformities causing respiratory compromise. The procedure involves spinal fusion to stabilize the vertebral column. Expected benefits include improved respiratory function and prevention of further deformity. Surgical risks include infection, nerve damage, and the need for revision surgery. Post-operative care involves intensive rehabilitation and monitoring for complications.
The care team typically includes geneticists, orthopedic surgeons, physical therapists, and social workers. Interventions focus on optimizing physical function, managing complications, and providing psychosocial support. Strategies include counseling and education for families to manage expectations and care needs. Family education is crucial for understanding the condition and its management. Long-term monitoring involves regular follow-ups to assess growth, development, and emerging complications.
When to See a Doctor for Dyssegmental dysplasia, Silverman-Handmaker type
- Severe respiratory distress — this is an emergency because it can lead to life-threatening complications without immediate intervention.
- Sudden loss of consciousness — this is critical as it may indicate severe neurological or cardiovascular issues.
- Acute, unexplained pain in the limbs — this could signal a fracture or other serious musculoskeletal issue that requires urgent care.
- Progressive difficulty in movement — this is significant as it may indicate worsening of skeletal abnormalities; consult a specialist.
- Persistent joint swelling — this could suggest inflammation or other complications; medical evaluation is recommended.
- Delayed developmental milestones — this is concerning as it may reflect underlying complications; early intervention is crucial.
- Mild joint stiffness — monitor for changes in mobility and manage with physical therapy as advised by a healthcare provider.
- Occasional fatigue — monitor energy levels and ensure adequate rest and nutrition; consult a doctor if it worsens.
Dyssegmental dysplasia, Silverman-Handmaker type — Frequently Asked Questions
Is this condition hereditary?
Dyssegmental dysplasia, Silverman-Handmaker type, is inherited in an autosomal recessive pattern. This means both parents must carry one copy of the mutated gene to pass it to their child. De novo mutations are rare but possible. Carriers typically do not show symptoms but can pass the gene to offspring. Genetic counseling is recommended for families with a history of this condition.
What is the life expectancy for someone with this condition?
Life expectancy is often reduced, with many affected individuals not surviving beyond infancy. Prognosis depends on the severity of skeletal and respiratory complications. Respiratory failure is a common cause of mortality. Early interventions and supportive care can improve quality of life but may not significantly extend lifespan. Families should discuss realistic expectations with healthcare providers.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves prenatal imaging and genetic testing. The time from first symptoms to diagnosis can vary but is often identified prenatally or shortly after birth. Geneticists and pediatric specialists are commonly involved in the diagnostic process. Delays can occur if initial symptoms are subtle or atypical. Confirmation is usually achieved through molecular genetic testing.
Are there any new treatments or clinical trials available?
Research is ongoing, with some promising studies focusing on gene therapy. Novel approaches aim to correct the underlying genetic defects. ClinicalTrials.gov is a resource for finding current trials. Patients should discuss potential participation with their healthcare providers. New treatments may take years to become widely available.
How does this condition affect daily life and activities?
Mobility is often significantly impacted, requiring assistive devices for movement. Educational needs may be specialized due to physical limitations. Social and emotional challenges include coping with chronic illness and potential isolation. Family burden can be substantial, necessitating support and respite care. Adaptive technologies and therapies can greatly enhance quality of life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.
Arikawa-Hirasawa E, Wilcox WR, Yamada Y · Am J Med Genet · 2001 · PMID: 11891676
- 2.Dyssegmental dysplasia Silverman-Handmaker type in a consanguineous Druze Lebanese family: long term survival and documentation of the natural history.
Prabhu VG, Kozma C, Leftridge CA et al. · Am J Med Genet · 1998 · PMID: 9450878
- 3.Dyssegmental dysplasia, Silverman-Handmaker type: A challenging antenatal diagnosis in a dizygotic twin pregnancy.
Basalom S, Trakadis Y, Shear R et al. · Mol Genet Genomic Med · 2018 · PMID: 29526034
- 4.Dyssegmental dysplasia, Silverman-Handmaker type: prenatal ultrasound findings and molecular analysis.
Ladhani NN, Chitayat D, Nezarati MM et al. · Prenat Diagn · 2013 · PMID: 23836246
- 5.Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
Arikawa-Hirasawa E, Wilcox WR, Le AH et al. · Nat Genet · 2001 · PMID: 11279527
- 6.Phenotypic and molecular characterization of a novel case of dyssegmental dysplasia, Silverman-Handmaker type.
Rieubland C, Jacquemont S, Mittaz L et al. · Eur J Med Genet · 2010 · PMID: 20542149
- 7.Schwartz-Jampel syndrome and perlecan deficiency.
Stum M, Davoine CS, Fontaine B et al. · Acta Myol · 2005 · PMID: 16550923
- 8.Perlecan: a review of its role in neurologic and musculoskeletal disease.
Lavorgna TR, Gressett TE, Chastain WH et al. · Front Physiol · 2023 · PMID: 37324385
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-01